期刊文献+

单药周剂量紫杉醇脂质体治疗老年激素难治性前列腺癌3例 被引量:4

暂未订购
导出
摘要 目的:观察老年激素难治性前列腺癌患者用单药周剂量紫杉醇脂质体作为一线方案化疗的有效性和安全性。方法:采用单药紫杉醇脂质体静脉滴注,剂量:35mg/m2,每周1次,连用6周后休息2周为1个周期。随后评价疗效。结果:2例患者获得部分缓解,1例为稳定;副反应仅见Ⅰ度骨髓抑制。结论:单药周剂量紫杉醇脂质体治疗老年晚期前列腺癌安全性好,疗效需要扩大病例数进一步观察。
出处 《实用医学杂志》 CAS 北大核心 2009年第21期3669-3671,共3页 The Journal of Practical Medicine
基金 广西青年科学基金(编号:0640061)
  • 相关文献

参考文献8

  • 1Newman L A, Lee C T, Parekh L P, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee [J]. Cancer, 2006, 106( 1 ) : 188-195.
  • 2顾方六,刘玉立.50年泌尿男生殖系肿瘤发病和构成情况的变迁[J].中华泌尿外科杂志,2002,23(2):88-90. 被引量:137
  • 3叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:170
  • 4Mendiratta P, Armstrong A J, George D J. Current standard and investigational approaches to the management of hormone-refractory prostate cancer [J]. Rev Urol, 2007, 9 (Suppl 1 ) :S9-S19.
  • 5Fennely D, Aghajanian C, Shapiro F, et al. Phase I and pharmacologic study of paelitaxel administered weekly in patients with relapsed ovarian cancer[J]. J Clin Oncol, 1997, 15(2): 187- 192.
  • 6Hainsworth J, Burris H, Erland J, et al. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer [J]. J Olin Oncol, 1998, 16(6) : 2164-2168.
  • 7Berry W, Dakhil S, Gregurich M A, et al. Phase Ⅱ trial of singleagent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate [J]. Semin Oncol, 2001, 28 (4 Suppl 15) :8-15.
  • 8Tester W, Ackler J, Tijani L, et al. Phase I / II study of weekly docetaxel and vinblastine in the treatment of metastatic hormonerefractory prostate carcinoma[J]. Cancer J, 2006, 12(4) :299-304.

二级参考文献5

共引文献301

同被引文献26

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部